Suppr超能文献

免疫球蛋白G稳态设定点和恢复时间在血浆置换供体安全监测中的应用:一项回顾性观察队列研究。

Use of immunoglobulin G homeostatic set point and recovery time in plasmapheresis donor safety monitoring: A retrospective observational cohort study.

作者信息

Warner Janet V, Drinkwater Michael J, Chu Gerard J, Kelly Shane, McComish Jeremy S

机构信息

Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Queensland, Australia.

School of Mathematics and Physics, University of Queensland, Brisbane, Queensland, Australia.

出版信息

Vox Sang. 2025 Apr;120(4):374-382. doi: 10.1111/vox.13800. Epub 2025 Jan 29.

Abstract

BACKGROUND AND OBJECTIVES

Serum immunoglobulin G (IgG) and total protein are used to monitor plasmapheresis donor safety. However, there is a lack of information from large donor cohorts to determine the best use of these measurements.

MATERIALS AND METHODS

We identified 230,144 plasmapheresis donors making their first donation between 1 July 2020 and 31 March 2024. IgG and total protein were measured prior to the first donation and then annually, following our donor safety monitoring protocol. We considered individuals who had not donated for 12 months to estimate intra-individual biological variability of IgG. We compared four models to predict which donors would develop IgG < 6 g/L.

RESULTS

The IgG reference interval for the cohort was 7.67-15.6 g/L. IgG declines 5%-11% after the age of 45 years. The intra-individual biological variability of IgG (5.2%) is small, indicating that there is homeostatic set point for individual IgG. IgG is reduced by plasmapheresis but recovers to recruitment level after 12 weeks. When plasma is donated every 2-3 weeks, mean IgG plateaus 1 g/L below recruitment concentration. IgG at recruitment is the best predictor of which donors will have IgG < 6 g/L after a year of donations. Total protein is a low-value test in this context.

CONCLUSION

Plasmapheresis is safe and sustainable for almost every donor, at the 2-weekly frequency allowed in Australia. The donors most likely to experience unacceptably low IgG are those with very low recruitment IgG levels. These donors could be recommended 12-week intervals between donations or other donation types.

摘要

背景与目的

血清免疫球蛋白G(IgG)和总蛋白用于监测单采血浆献血者的安全性。然而,缺乏来自大量献血者队列的信息来确定这些检测指标的最佳用途。

材料与方法

我们确定了230144名单采血浆献血者,他们在2020年7月1日至2024年3月31日期间首次献血。按照我们的献血者安全监测方案,在首次献血前以及之后每年测量IgG和总蛋白。我们考虑那些有12个月未献血的个体,以估计IgG的个体内生物学变异性。我们比较了四种模型,以预测哪些献血者的IgG会降至<6g/L。

结果

该队列的IgG参考区间为7.67 - 15.6g/L。45岁以后,IgG下降5% - 11%。IgG的个体内生物学变异性较小(5.2%),表明个体IgG存在稳态设定点。单采血浆会使IgG降低,但12周后会恢复到采血时的水平。当每2 - 3周采集一次血浆时,平均IgG稳定在比采血浓度低1g/L的水平。采血时的IgG是预测哪些献血者在献血一年后IgG会<6g/L的最佳指标。在此背景下,总蛋白检测价值较低。

结论

在澳大利亚允许的两周一次的频率下,单采血浆对几乎所有献血者来说都是安全且可持续的。最有可能出现不可接受的低IgG水平的献血者是那些采血时IgG水平非常低的人。对于这些献血者,可以建议延长至12周的献血间隔或采用其他献血类型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验